Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00906_DB00976_nanopub.RADWfGDd-hsLaWdMfI3h1W1kIz70T8FNmW2oI3Sj9ljgA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00906_DB00976 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00906_DB00976 label "DDI between Tiagabine and Telithromycin - The strong CYP3A4 inhibitor, Telithromycin, may decrease the metabolism and clearance of Tiagabine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Tiagabine if Telithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00906_DB00976]" assertion.
- drugbank_resource:DB00906_DB00976 identifier "drugbank_resource:DB00906_DB00976" assertion.
- drugbank_resource:DB00906_DB00976 title "DDI between Tiagabine and Telithromycin - The strong CYP3A4 inhibitor, Telithromycin, may decrease the metabolism and clearance of Tiagabine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Tiagabine if Telithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00976 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00906_DB00976 assertion.
- drugbank:DB00906 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00906_DB00976 assertion.